ArticleBlood advances2021

Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma.

Nicola Ferrari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.